177 related articles for article (PubMed ID: 34900723)
21. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
22. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
[TBL] [Abstract][Full Text] [Related]
23. Critical roles of the lncRNA CASC11 in tumor progression and cancer metastasis: The biomarker and therapeutic target potential.
Wang B; Xu W; Hu C; Liu K; Chen J; Guo C; Yuan C
Genes Dis; 2022 Mar; 9(2):325-333. PubMed ID: 35224149
[TBL] [Abstract][Full Text] [Related]
24. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
[TBL] [Abstract][Full Text] [Related]
25. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
[TBL] [Abstract][Full Text] [Related]
27. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
28. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
29. LncRNA-LALR1 upregulates small nucleolar RNA SNORD72 to promote growth and invasion of hepatocellular carcinoma.
Mao LH; Chen SY; Li XQ; Xu F; Lei J; Wang QL; Luo LY; Cao HY; Ge X; Ran T; Li X; Zou M; Zhou ZH; Wu XL; He S
Aging (Albany NY); 2020 Mar; 12(5):4527-4546. PubMed ID: 32160589
[TBL] [Abstract][Full Text] [Related]
30. A review on the role of CASC11 in cancers.
Ghafouri-Fard S; Harsij A; Hussen BM; Taheri M; Sharifi G
Front Cell Dev Biol; 2023; 11():1131199. PubMed ID: 37427385
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Liu F; Zhu C; Gao P; Zheng S; Li C
Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
[TBL] [Abstract][Full Text] [Related]
32. LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11.
Su X; Zhang J; Luo X; Yang W; Liu Y; Liu Y; Shan Z
Onco Targets Ther; 2019; 12():8117-8123. PubMed ID: 31632064
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
Wen M; Kwon Y; Wang Y; Mao JH; Wei G
Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
[TBL] [Abstract][Full Text] [Related]
34. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
Luo H; Xu C; Le W; Ge B; Wang T
J Cell Biochem; 2019 Aug; 120(8):13487-13493. PubMed ID: 30916832
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer.
Fu Y; Zhang P; Nan H; Lu Y; Zhao J; Yang M; Song Q
Gene; 2019 Jul; 704():91-96. PubMed ID: 30965130
[TBL] [Abstract][Full Text] [Related]
36. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N
Yang Y; Yan Y; Yin J; Tang N; Wang K; Huang L; Hu J; Feng Z; Gao Q; Huang A
Signal Transduct Target Ther; 2023 Feb; 8(1):63. PubMed ID: 36765030
[TBL] [Abstract][Full Text] [Related]
37. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Wei X; You X; Zhang J; Zhou C
Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423
[TBL] [Abstract][Full Text] [Related]
39. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
40. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Oncol Lett; ; . PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
